Risk stratification system and web-based nomogram constructed for predicting the overall survival of primary osteosarcoma patients after surgical resection

被引:3
|
作者
Gao, Bing [1 ]
Wang, Meng-Die [2 ]
Li, Yanan [3 ]
Huang, Fei [1 ]
机构
[1] Jilin Univ, China Japan Union Hosp, Dept Orthoped, Changchun, Peoples R China
[2] Jilin Univ, China Japan Union Hosp, Dept Neurol, Changchun, Peoples R China
[3] First Hosp Jilin Univ, Dept Pediat, Changchun, Peoples R China
关键词
osteosarcoma; surgical resection; overall survival; nomogram; risk stratification; web application; LIMB-SALVAGE; PROGNOSTIC NOMOGRAM; CANCER; AMPUTATION; CHEMOTHERAPY; SARCOMAS; SURGERY;
D O I
10.3389/fpubh.2022.949500
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Previous prediction models of osteosarcoma have not focused on survival in patients undergoing surgery, nor have they distinguished and compared prognostic differences among amputation, radical and local resection. This study aimed to establish and validate the first reliable prognostic nomogram to accurately predict overall survival (OS) after surgical resection in patients with osteosarcoma. On this basis, we constructed a risk stratification system and a web-based nomogram. Methods: We enrolled all patients with primary osteosarcoma who underwent surgery between 2004 and 2015 in the Surveillance, Epidemiology, and End Results (SEER) database. In patients with primary osteosarcoma after surgical resection, univariate and multivariate cox proportional hazards regression analyses were utilized to identify independent prognostic factors and construct a novel nomogram for the 1-, 3-, and 5-year OS. Then the nomogram's predictive performance and clinical utility were evaluated by the concordance index (C-index), receiver operating characteristic (ROC) curves, calibration curves, and decision curve analysis (DCA). Result: This study recruited 1,396 patients in all, with 837 serving as the training set (60%) and 559 as the validation set (40%). After COX regression analysis, we identified seven independent prognostic factors to develop the nomogram, including age, primary site, histological type, disease stage, AJCC stage, tumor size, and surgical method. The C-index indicated that this nomogram is considerably more accurate than the AJCC stage in predicting OS [Training set (HR: 0.741, 95% CI: 0.726-0.755) vs. (HR: 0.632, 95% CI: 0.619-0.645); Validation set (HR: 0.735, 95% CI: 0.718-0.753) vs. (HR: 0.635, 95% CI: 0.619-0.652)].Moreover, the area under ROC curves, the calibration curves, and DCA demonstrated that this nomogram was significantly superior to the AJCC stage, with better predictive performance and more net clinical benefits. Conclusion: This study highlighted that radical surgery was the first choice for patients with primary osteosarcoma since it provided the best survival prognosis. We have established and validated a novel nomogram that could objectively predict the overall survival of patients with primary osteosarcoma after surgical resection. Furthermore, a risk stratification system and a web-based nomogram could be applied in clinical practice to assist in therapeutic decision-making.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Web-based nomogram and risk stratification system constructed for predicting the overall survival of older adults with primary kidney cancer after surgical resection
    Jiang, Liming
    Wang, Chengcheng
    Tong, Yuexin
    Jiang, Jiajia
    Zhao, Dongxu
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (13) : 11873 - 11889
  • [2] Web-based nomogram and risk stratification system constructed for predicting the overall survival of older adults with primary kidney cancer after surgical resection
    Liming Jiang
    Chengcheng Wang
    Yuexin Tong
    Jiajia Jiang
    Dongxu Zhao
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 11873 - 11889
  • [3] Nomogram predicting overall survival after surgical resection for retroperitoneal leiomyosarcoma patients
    Zhuang, Aojia
    Yue, Xuetong
    Tong, Hanxing
    Zhang, Yong
    He, Fuchu
    Lu, Weiqi
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [4] A nomogram for predicting overall survival in patients with parathyroid cancer: A novel web-based calculator
    Yin, Fangxu
    Hou, Chong
    Wang, Song
    Wang, Xiaohong
    Yang, Zhenlin
    ASIAN JOURNAL OF SURGERY, 2023, 46 (10) : 4169 - 4177
  • [5] The novel dynamic nomogram and risk classification system constructed for predicting post-surgical overall survival and mortality risk in primary chondrosarcoma: a population study based on SEER database
    Liming Jiang
    Yan Gong
    Jiajia Jiang
    Dongxu Zhao
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 12765 - 12778
  • [6] The novel dynamic nomogram and risk classification system constructed for predicting post-surgical overall survival and mortality risk in primary chondrosarcoma: a population study based on SEER database
    Jiang, Liming
    Gong, Yan
    Jiang, Jiajia
    Zhao, Dongxu
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (14) : 12765 - 12778
  • [7] The development and external validation of a web-based nomogram for predicting overall survival with Ewing sarcoma in children
    Chen, Yi
    Liu, Zirui
    Wang, Yaobin
    Zhan, Hongwei
    Liu, Jinmin
    Niu, Yongkang
    Yang, Ao
    Teng, Fei
    Li, Jinfeng
    Geng, Bin
    Xia, Yayi
    JOURNAL OF CHILDRENS ORTHOPAEDICS, 2024, 18 (02) : 236 - 245
  • [8] A novel risk score model based on eight genes and a nomogram for predicting overall survival of patients with osteosarcoma
    Guangzhi Wu
    Minglei Zhang
    BMC Cancer, 20
  • [9] A novel risk score model based on eight genes and a nomogram for predicting overall survival of patients with osteosarcoma
    Wu, Guangzhi
    Zhang, Minglei
    BMC CANCER, 2020, 20 (01)
  • [10] A practical nomogram and risk stratification system for predicting survival outcomes in neuroblastoma patients: a SEER population-based study
    Zhuo, Xiaoyu
    Xia, Liangfeng
    Tang, Wenjing
    He, Wenqi
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (13) : 12285 - 12296